Skip to content
View as Markdown

COMPARISON

Best website for IPO analysis in India (October 2026)

IPO websites for Indian investors compared on subscription data, GMP, financials, valuation, verdicts and listing performance, and what each is best for.

By , Research lead Updated 5 min read How we research these comparisons

The best website for IPO analysis in India is Tapetide, which puts subscription, an unofficial GMP history and offer-document financials on one free page. Trendlyne adds peer tables and listing-gain statistics, MarketsMojo gives a verdict, and NSE shows its own record of bids on NSE.

Tapetide is our product. We rank it first for IPO research because it is the only site here that shows GMP, subscription and offer-document financials together. It has no app and gives no verdicts. Everything below was checked on each site's own IPO pages on 25 October 2026.

Which IPO website gives you the most?

Rank Website Best for Subscription data GMP Financials and valuation Verdict App
1 Tapetide Everything on one page Overall; bids received Day-wise, labelled unofficial 3 years, KPIs, pre and post P/E None None
2 Trendlyne Peers and listing-gain history QIB, HNI, retail, total Explainer only Financials, peers, strengths, risks None Android, iOS
3 Moneycontrol Dates, allotment and news By category Not shown Financials User poll Android, iOS
4 MarketsMojo A quick verdict Not checked Not shown Not checked Avoid, Neutral, Subscribe Android, iOS
5 Screener.in Quick valuation of upcoming issues Total and by category Not shown P/E and ROCE in the list None Android
6 NSE NSE's own bid record Bids by category Not shown None on the page None Not checked

Five of the six IPO pages loaded without login on 25 October 2026; we did not confirm MarketsMojo's. GMP is unofficial and not a forecast.

Tapetide: subscription, GMP and financials on one page

Tapetide's IPO tracker lists open, upcoming, expected, awaiting-listing and recently listed issues, with 400 listed IPOs tracked. Each IPO page covers:

  • Issue basics: price band, lot size, the cost of one lot at cut-off, issue size and the full timetable from opening to listing.
  • Subscription: overall times subscribed and the bids received.
  • GMP: a day-wise table with the premium, sauda rate, estimated listing price and gain per lot, labelled unofficial and indicative.
  • Allocation: reservation by investor category, application sizes in lots and the anchor allocation.
  • Valuation and financials: pre- and post-issue EPS, P/E and price to book, KPIs, and three years of financials from the offer document.
  • After listing: listing gain and return since issue for recent listings.

Cons: no buy or avoid verdict; no mobile app; no app-store ratings, since there is no app. Best for: investors who want the numbers in one place and will make their own call.

Trendlyne: peers and listing-gain history

Trendlyne's IPO dashboard covers mainboard and SME issues with QIB, HNI, retail and total subscription, and links to each prospectus.

  • Detail pages: issue details, RHP, financials with cash flow, an IPO report, strengths, risks and a peer table with P/E, PEG, ROE and growth.
  • History: on 25 October 2026 its last-12-months view showed 262 IPOs opened in profit, 103 in loss, and an average listing gain of 12.1%.
  • Cons: its GMP page explains GMP but shows no figures.
  • Best for: comparing an IPO with listed peers.

Moneycontrol: dates, allotment and news

Moneycontrol's IPO hub shows open, upcoming, closed and listed issues.

  • Includes: times subscribed by category; allotment, refund, demat-credit and listing dates; an allotment-status check; listing gain and today's gain for listed IPOs; financials, news and a forum.
  • Paid: Moneycontrol PRO adds IPO analysis with recommendations, from ₹99 a month plus GST with a coupon.
  • Cons: its page description mentions GMP, but we found no GMP figures on the pages checked; the free site shows ads.
  • Best for: tracking allotment and listing dates alongside news.

MarketsMojo: a quick verdict

MarketsMojo gives each IPO an Avoid, Neutral or Subscribe verdict, with price band and dates. Its site shows a SEBI Investment Adviser registration, INA000012528.

  • Cons: the verdict is the main output; we did not find GMP. Its full research needs a paid package (₹9,999 for one year on 25 October 2026).
  • Best for: investors who want an adviser's view. See our MarketsMojo review.

Screener.in: quick valuation of upcoming issues

Screener.in's IPO page lists upcoming issues with subscription period, price band, listing date, market cap, subscription, P/E and ROCE. It has Recent IPOs and Below IPO Price tabs.

  • Cons: no GMP or detailed offer-document view on the list.
  • Best for: a fast valuation check across upcoming issues.

NSE: the exchange's own bid record

NSE's upcoming-issues page shows each issue's dates, status and NSE bid details across categories: shares offered, bids and times subscribed. It has a CSV download.

  • Cons: no GMP, financials or verdicts; the page covers NSE bid details.
  • Best for: checking NSE's own bid figures.

Which should you choose?

  • One page with every number: Tapetide.
  • Peer comparison and listing history: Trendlyne.
  • Allotment and listing dates with news: Moneycontrol.
  • A subscribe or avoid view: MarketsMojo.
  • A quick P/E and ROCE scan: Screener.in.
  • NSE's own bid count: NSE.

How we ranked them

We opened each site's IPO list and at least one IPO detail page on 25 October 2026 and recorded what was shown free. Breadth on one page ranked highest, then financial and valuation depth, then listing history. GMP is unofficial grey-market data, not published by NSE, BSE, SEBI or the issuer, and should never decide an application on its own. Tapetide is our product; email support@tapetide.com if anything here is out of date. This page is for information only and is not investment advice.

Questions people ask

What is the best website for IPO analysis in India?
Tapetide, which puts subscription, an unofficial GMP history, valuation and offer-document financials on one free page. Trendlyne adds peer tables and listing-gain statistics. MarketsMojo gives an Avoid, Neutral or Subscribe verdict. NSE shows the exchange's own bid figures for NSE.
Which website shows IPO GMP?
Of the sites here, only Tapetide showed GMP figures on 25 October 2026, with a day-wise history and a note that GMP is unofficial. Trendlyne has a GMP explainer page with no figures. We found no GMP figures on the Moneycontrol, Screener.in, MarketsMojo or NSE pages we checked.
Is IPO GMP reliable?
No. GMP is an unofficial premium from an unregulated grey market. It is not published by NSE, BSE, SEBI or the issuer, and it can change sharply. Trendlyne's explainer also says it is not always a reliable indicator of listing price.
Where can I see live IPO subscription status?
NSE's upcoming issues page shows bids and subscription across categories. Moneycontrol, Trendlyne, Screener.in and Tapetide show subscription by category or in total on their IPO pages, free.
Which site gives a subscribe or avoid verdict?
MarketsMojo rates each IPO Avoid, Neutral or Subscribe. Moneycontrol shows a user poll of subscribe, avoid or not sure. Tapetide, Trendlyne, Screener.in and NSE give data, not verdicts.
Which site shows IPO financials and valuation?
Tapetide shows three years of offer-document financials, KPIs and pre- and post-issue EPS, P/E and price to book. Trendlyne shows financials, strengths, risks and a peer table. Screener.in lists P/E and ROCE for upcoming issues.
How did recent IPOs perform after listing?
Trendlyne's dashboard showed that over the last 12 months 262 IPOs opened in profit and 103 in loss, with an average listing gain of 12.1%, on 25 October 2026. Tapetide lists each recent IPO's listing gain and return since issue.
Do I need to pay for IPO analysis?
No. Five of the six IPO pages loaded without login when we checked; we did not confirm MarketsMojo's. Moneycontrol PRO adds IPO analysis with recommendations, and MarketsMojo's verdicts sit inside its IPO page.
Does Tapetide have an IPO app?
No. Tapetide is web-only. Moneycontrol, Trendlyne and MarketsMojo have Android and iOS apps. Tapetide is our product.

About the author. Sanjay Mehta leads research at Tapetide and writes its platform comparisons and market data reports.

Tapetide provides research data and tools. Nothing on this page is investment advice.